Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Identification of Subsets of Enteroaggregative Escherichia coli Associated with Diarrheal Disease among Under 5 Years of Age Children from Rural Gambia.

Ikumapayi UN, Boisen N, Hossain MJ, Betts M, Lamin M, Saha D, Kwambana-Adams B, Dione M, Adegbola RA, Roca A, Nataro JP, Antonio M.

Am J Trop Med Hyg. 2017 Oct;97(4):997-1004. doi: 10.4269/ajtmh.16-0705. Epub 2017 Aug 18.

2.

Impact of the introduction of pneumococcal conjugate vaccination on pneumonia in The Gambia: population-based surveillance and case-control studies.

Mackenzie GA, Hill PC, Sahito SM, Jeffries DJ, Hossain I, Bottomley C, Uchendu U, Ameh D, Ndiaye M, Osuorah CD, Adeyemi O, Pathirana J, Olatunji Y, Abatan B, Ahameefula E, Muhammad BS, Fombah AE, Saha D, Mackenzie R, Plumb I, Akano A, Ebruke B, Ideh RC, Kuti B, Githua P, Olutunde E, Ofordile O, Green E, Usuf E, Badji H, Ikumapayi UNA, Manjang A, Salaudeen R, Nsekpong ED, Jarju S, Antonio M, Sambou S, Ceesay L, Lowe-Jallow Y, Sowe D, Jasseh M, Mulholland K, Knoll M, Levine OS, Howie SR, Adegbola RA, Greenwood BM, Corrah T.

Lancet Infect Dis. 2017 Sep;17(9):965-973. doi: 10.1016/S1473-3099(17)30321-3. Epub 2017 Jun 7. Erratum in: Lancet Infect Dis. 2018 Jul;18(7):715.

3.

The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillance.

Gehre F, Otu J, Kendall L, Forson A, Kwara A, Kudzawu S, Kehinde AO, Adebiyi O, Salako K, Baldeh I, Jallow A, Jallow M, Dagnra A, Dissé K, Kadanga EA, Idigbe EO, Onubogu C, Onyejepu N, Gaye-Diallo A, Ba-Diallo A, Rabna P, Mane M, Sanogo M, Diarra B, Dezemon Z, Sanou A, Senghore M, Kwambana-Adams BA, Demba E, Faal-Jawara T, Kumar S, Tientcheu LD, Jallow A, Ceesay S, Adetifa I, Jaye A, Pallen MJ, D'Alessandro U, Kampmann B, Adegbola RA, Mboup S, Corrah T, de Jong BC, Antonio M.

BMC Med. 2016 Nov 3;14(1):160.

4.

Childhood pneumonia and crowding, bed-sharing and nutrition: a case-control study from The Gambia.

Howie SR, Schellenberg J, Chimah O, Ideh RC, Ebruke BE, Oluwalana C, Mackenzie G, Jallow M, Njie M, Donkor S, Dionisio KL, Goldberg G, Fornace K, Bottomley C, Hill PC, Grant CC, Corrah T, Prentice AM, Ezzati M, Greenwood BM, Smith PG, Adegbola RA, Mulholland K.

Int J Tuberc Lung Dis. 2016 Oct;20(10):1405-1415.

5.

High genetic diversity of Staphylococcus aureus strains colonising the nasopharynx of Gambian villagers before widespread use of pneumococcal conjugate vaccines.

Ebruke C, Dione MM, Walter B, Worwui A, Adegbola RA, Roca A, Antonio M.

BMC Microbiol. 2016 Mar 12;16:38. doi: 10.1186/s12866-016-0661-3.

6.

Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study.

Mackenzie GA, Hill PC, Jeffries DJ, Hossain I, Uchendu U, Ameh D, Ndiaye M, Adeyemi O, Pathirana J, Olatunji Y, Abatan B, Muhammad BS, Fombah AE, Saha D, Plumb I, Akano A, Ebruke B, Ideh RC, Kuti B, Githua P, Olutunde E, Ofordile O, Green E, Usuf E, Badji H, Ikumapayi UNA, Manjang A, Salaudeen R, Nsekpong ED, Jarju S, Antonio M, Sambou S, Ceesay L, Lowe-Jallow Y, Jasseh M, Mulholland K, Knoll M, Levine OS, Howie SR, Adegbola RA, Greenwood BM, Corrah T.

Lancet Infect Dis. 2016 Jun;16(6):703-711. doi: 10.1016/S1473-3099(16)00054-2. Epub 2016 Feb 18.

7.

Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2-29 Years.

Diallo A, Sow SO, Idoko OT, Hirve S, Findlow H, Preziosi MP, Elie C, Kulkarni PS, Parulekar V, Diarra B, Cheick Haidara F, Diallo F, Tapia M, Akinsola AK, Adegbola RA, Bavdekar A, Juvekar S, Chaumont J, Martellet L, Marchetti E, LaForce MF, Plikaytis BD, Enwere GC, Tang Y, Borrow R, Carlone G, Viviani S.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S521-30. doi: 10.1093/cid/civ518.

8.

Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age.

Tapia MD, Findlow H, Idoko OT, Preziosi MP, Kulkarni PS, Enwere GC, Elie C, Parulekar V, Sow SO, Haidara FC, Diallo F, Doumbia M, Akinsola AK, Adegbola RA, Kampmann B, Chaumont J, Martellet L, Marchetti E, Viviani S, Tang Y, Plikaytis BD, LaForce FM, Carlone G, Borrow R.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S514-20. doi: 10.1093/cid/civ672.

9.

Ethical Challenges and Lessons Learned During the Clinical Development of a Group A Meningococcal Conjugate Vaccine.

Martellet L, Sow SO, Diallo A, Hodgson A, Kampmann B, Hirve S, Tapia M, Haidara FC, Ndiaye A, Diarra B, Ansah PO, Akinsola A, Idoko OT, Adegbola RA, Bavdekar A, Juvekar S, Viviani S, Enwere GC, Marchetti E, Chaumont J, Makadi MF, Pallardy F, Kulkarni PS, Preziosi MP, LaForce FM.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S422-7. doi: 10.1093/cid/civ598. Review.

10.

Occurrence, Species, and Organ Differences in Bioaccumulation Patterns of Phthalate Esters in Municipal Domestic Water Supply Lakes in Ibadan, Nigeria.

Adeogun AO, Ibor OR, Omiwole RA, Hassan T, Adegbola RA, Adewuyi GO, Arukwe A.

J Toxicol Environ Health A. 2015;78(12):761-77. doi: 10.1080/15287394.2015.1030487.

PMID:
26090560
11.

Temporal changes in nasopharyngeal carriage of Streptococcus pneumoniae serotype 1 genotypes in healthy Gambians before and after the 7-valent pneumococcal conjugate vaccine.

Ebruke C, Roca A, Egere U, Darboe O, Hill PC, Greenwood B, Wren BW, Adegbola RA, Antonio M.

PeerJ. 2015 Apr 30;3:e903. doi: 10.7717/peerj.903. eCollection 2015.

12.

Environmental occurrence and biota concentration of phthalate esters in Epe and Lagos Lagoons, Nigeria.

Adeogun AO, Ibor OR, Omogbemi ED, Chukwuka AV, Adegbola RA, Adewuyi GA, Arukwe A.

Mar Environ Res. 2015 Jul;108:24-32. doi: 10.1016/j.marenvres.2015.04.002. Epub 2015 Apr 15.

PMID:
25935094
13.

Population genetic analyses of Helicobacter pylori isolates from Gambian adults and children.

Secka O, Moodley Y, Antonio M, Berg DE, Tapgun M, Walton R, Worwui A, Thomas V, Corrah T, Thomas JE, Adegbola RA.

PLoS One. 2014 Oct 13;9(10):e109466. doi: 10.1371/journal.pone.0109466. eCollection 2014.

14.

Predicting the impact of new pneumococcal conjugate vaccines: serotype composition is not enough.

Hausdorff WP, Hoet B, Adegbola RA.

Expert Rev Vaccines. 2015 Mar;14(3):413-28. doi: 10.1586/14760584.2015.965160. Epub 2014 Sep 30. Review.

PMID:
25266168
15.

Carriage of Streptococcus pneumoniae and other respiratory bacterial pathogens in low and lower-middle income countries: a systematic review and meta-analysis.

Adegbola RA, DeAntonio R, Hill PC, Roca A, Usuf E, Hoet B, Greenwood BM.

PLoS One. 2014 Aug 1;9(8):e103293. doi: 10.1371/journal.pone.0103293. eCollection 2014. Review.

16.

Shigella isolates from the global enteric multicenter study inform vaccine development.

Livio S, Strockbine NA, Panchalingam S, Tennant SM, Barry EM, Marohn ME, Antonio M, Hossain A, Mandomando I, Ochieng JB, Oundo JO, Qureshi S, Ramamurthy T, Tamboura B, Adegbola RA, Hossain MJ, Saha D, Sen S, Faruque AS, Alonso PL, Breiman RF, Zaidi AK, Sur D, Sow SO, Berkeley LY, O'Reilly CE, Mintz ED, Biswas K, Cohen D, Farag TH, Nasrin D, Wu Y, Blackwelder WC, Kotloff KL, Nataro JP, Levine MM.

Clin Infect Dis. 2014 Oct;59(7):933-41. doi: 10.1093/cid/ciu468. Epub 2014 Jun 23.

17.

Etiology of severe childhood pneumonia in the Gambia, West Africa, determined by conventional and molecular microbiological analyses of lung and pleural aspirate samples.

Howie SR, Morris GA, Tokarz R, Ebruke BE, Machuka EM, Ideh RC, Chimah O, Secka O, Townend J, Dione M, Oluwalana C, Njie M, Jallow M, Hill PC, Antonio M, Greenwood B, Briese T, Mulholland K, Corrah T, Lipkin WI, Adegbola RA.

Clin Infect Dis. 2014 Sep 1;59(5):682-5. doi: 10.1093/cid/ciu384. Epub 2014 May 27.

18.

Discovery and validation of biomarkers to guide clinical management of pneumonia in African children.

Huang H, Ideh RC, Gitau E, Thézénas ML, Jallow M, Ebruke B, Chimah O, Oluwalana C, Karanja H, Mackenzie G, Adegbola RA, Kwiatkowski D, Kessler BM, Berkley JA, Howie SR, Casals-Pascual C.

Clin Infect Dis. 2014 Jun;58(12):1707-15. doi: 10.1093/cid/ciu202. Epub 2014 Apr 2.

19.

Pneumococcal carriage in sub-Saharan Africa--a systematic review.

Usuf E, Bottomley C, Adegbola RA, Hall A.

PLoS One. 2014 Jan 20;9(1):e85001. doi: 10.1371/journal.pone.0085001. eCollection 2014. Review.

20.

Nasopharyngeal carriage of pneumococci four years after community-wide vaccination with PCV-7 in The Gambia: long-term evaluation of a cluster randomized trial.

Roca A, Dione MM, Bojang A, Townend J, Egere U, Darboe O, Howie SR, Hill PC, Adegbola RA, Greenwood BM, Antonio M.

PLoS One. 2013 Sep 27;8(9):e72198. doi: 10.1371/journal.pone.0072198. eCollection 2013.

21.

The effectiveness of conjugate Haemophilus influenzae type B vaccine in The Gambia 14 years after introduction.

Howie SR, Oluwalana C, Secka O, Scott S, Ideh RC, Ebruke BE, Balloch A, Sambou S, Erskine J, Lowe Y, Corrah T, Adegbola RA.

Clin Infect Dis. 2013 Dec;57(11):1527-34. doi: 10.1093/cid/cit598. Epub 2013 Sep 17.

22.

Incidence of Haemophilus influenzae type b disease in The Gambia 14 years after introduction of routine Haemophilus influenzae type b conjugate vaccine immunization.

Oluwalana C, Howie SR, Secka O, Ideh RC, Ebruke B, Sambou S, Erskine J, Lowe Y, Corrah T, Adegbola RA.

J Pediatr. 2013 Jul;163(1 Suppl):S4-7. doi: 10.1016/j.jpeds.2013.03.023.

PMID:
23773593
23.

Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study.

Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, Faruque AS, Zaidi AK, Saha D, Alonso PL, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ochieng JB, Omore R, Oundo JO, Hossain A, Das SK, Ahmed S, Qureshi S, Quadri F, Adegbola RA, Antonio M, Hossain MJ, Akinsola A, Mandomando I, Nhampossa T, Acácio S, Biswas K, O'Reilly CE, Mintz ED, Berkeley LY, Muhsen K, Sommerfelt H, Robins-Browne RM, Levine MM.

Lancet. 2013 Jul 20;382(9888):209-22. doi: 10.1016/S0140-6736(13)60844-2. Epub 2013 May 14.

PMID:
23680352
24.

Identifying recent adaptations in large-scale genomic data.

Grossman SR, Andersen KG, Shlyakhter I, Tabrizi S, Winnicki S, Yen A, Park DJ, Griesemer D, Karlsson EK, Wong SH, Cabili M, Adegbola RA, Bamezai RN, Hill AV, Vannberg FO, Rinn JL; 1000 Genomes Project, Lander ES, Schaffner SF, Sabeti PC.

Cell. 2013 Feb 14;152(4):703-13. doi: 10.1016/j.cell.2013.01.035.

25.

Population biology of Streptococcus pneumoniae in West Africa: multilocus sequence typing of serotypes that exhibit different predisposition to invasive disease and carriage.

Donkor ES, Adegbola RA, Wren BW, Antonio M.

PLoS One. 2013;8(1):e53925. doi: 10.1371/journal.pone.0053925. Epub 2013 Jan 16.

26.

Sustaining Vaccine Confidence in the 21st Century.

Hardt K, Schmidt-Ott R, Glismann S, Adegbola RA, Meurice FP.

Vaccines (Basel). 2013 Jun 24;1(3):204-24. doi: 10.3390/vaccines1030204. Review.

27.

Antimicrobial susceptibility and resistance patterns among Helicobacter pylori strains from The Gambia, West Africa.

Secka O, Berg DE, Antonio M, Corrah T, Tapgun M, Walton R, Thomas V, Galano JJ, Sancho J, Adegbola RA, Thomas JE.

Antimicrob Agents Chemother. 2013 Mar;57(3):1231-7. doi: 10.1128/AAC.00517-12. Epub 2012 Dec 21.

28.

Interferon-γ ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial.

Adetifa IM, Ota MO, Jeffries DJ, Lugos MD, Hammond AS, Battersby NJ, Owiafe PK, Donkor SD, Antonio M, Ibanga HB, Brookes RH, Aka P, Walton R, Adegbola RA, Hill PC.

Am J Respir Crit Care Med. 2013 Feb 15;187(4):439-45. doi: 10.1164/rccm.201208-1352OC. Epub 2012 Dec 6.

PMID:
23220919
29.

Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal carriage in newborns in rural Gambia: a randomised controlled trial.

Egere U, Townend J, Roca A, Akinsanya A, Bojang A, Nsekpong D, Greenwood B, Adegbola RA, Hill PC.

PLoS One. 2012;7(11):e49143. doi: 10.1371/journal.pone.0049143. Epub 2012 Nov 21.

30.

Exploring household economic impacts of childhood diarrheal illnesses in 3 African settings.

Rheingans R, Kukla M, Adegbola RA, Saha D, Omore R, Breiman RF, Sow SO, Onwuchekwa U, Nasrin D, Farag TH, Kotloff KL, Levine MM.

Clin Infect Dis. 2012 Dec;55 Suppl 4:S317-26. doi: 10.1093/cid/cis763.

31.

The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study.

Kotloff KL, Blackwelder WC, Nasrin D, Nataro JP, Farag TH, van Eijk A, Adegbola RA, Alonso PL, Breiman RF, Faruque AS, Saha D, Sow SO, Sur D, Zaidi AK, Biswas K, Panchalingam S, Clemens JD, Cohen D, Glass RI, Mintz ED, Sommerfelt H, Levine MM.

Clin Infect Dis. 2012 Dec;55 Suppl 4:S232-45. doi: 10.1093/cid/cis753. Erratum in: Clin Infect Dis. 2013 Jul;57(1):165.

32.

Comparative phylogenomics of Streptococcus pneumoniae isolated from invasive disease and nasopharyngeal carriage from West Africans.

Donkor ES, Stabler RA, Hinds J, Adegbola RA, Antonio M, Wren BW.

BMC Genomics. 2012 Oct 29;13:569. doi: 10.1186/1471-2164-13-569.

33.

Genome analysis of a highly virulent serotype 1 strain of Streptococcus pneumoniae from West Africa.

Williams TM, Loman NJ, Ebruke C, Musher DM, Adegbola RA, Pallen MJ, Weinstock GM, Antonio M.

PLoS One. 2012;7(10):e26742. doi: 10.1371/journal.pone.0026742. Epub 2012 Oct 17.

34.

Translating vaccine policy into action: a report from the Bill & Melinda Gates Foundation Consultation on the prevention of maternal and early infant influenza in resource-limited settings.

Ortiz JR, Neuzil KM, Ahonkhai VI, Gellin BG, Salisbury DM, Read JS, Adegbola RA, Abramson JS.

Vaccine. 2012 Nov 26;30(50):7134-40. doi: 10.1016/j.vaccine.2012.09.034. Epub 2012 Sep 29.

PMID:
23026690
35.

Pneumococcal antibody concentrations of subjects in communities fully or partially vaccinated with a seven-valent pneumococcal conjugate vaccine.

Ota MO, Roca A, Bottomley C, Hill PC, Egere U, Greenwood B, Adegbola RA.

PLoS One. 2012;7(8):e42997. doi: 10.1371/journal.pone.0042997. Epub 2012 Aug 14.

36.

PTX3 genetic variation and dizygotic twinning in the Gambia: could pleiotropy with innate immunity explain common dizygotic twinning in Africa?

Sirugo G, Edwards DR, Ryckman KK, Bisseye C, White MJ, Kebbeh B, Morris GA, Adegbola RA, Tacconelli A, Predazzi IM, Novelli G, Vannberg FO, Odunsi K, Page GP, Williams SM.

Ann Hum Genet. 2012 Nov;76(6):454-63. doi: 10.1111/j.1469-1809.2012.00723.x. Epub 2012 Jul 27.

37.

Effect of age and vaccination with a pneumococcal conjugate vaccine on the density of pneumococcal nasopharyngeal carriage.

Roca A, Bottomley C, Hill PC, Bojang A, Egere U, Antonio M, Darboe O, Greenwood BM, Adegbola RA.

Clin Infect Dis. 2012 Sep;55(6):816-24. doi: 10.1093/cid/cis554. Epub 2012 Jun 14.

38.

Childhood pneumonia as a global health priority and the strategic interest of the Bill & Melinda Gates Foundation.

Adegbola RA.

Clin Infect Dis. 2012 Apr;54 Suppl 2:S89-92. doi: 10.1093/cid/cir1051.

PMID:
22403237
39.

The genome of Mycobacterium africanum West African 2 reveals a lineage-specific locus and genome erosion common to the M. tuberculosis complex.

Bentley SD, Comas I, Bryant JM, Walker D, Smith NH, Harris SR, Thurston S, Gagneux S, Wood J, Antonio M, Quail MA, Gehre F, Adegbola RA, Parkhill J, de Jong BC.

PLoS Negl Trop Dis. 2012;6(2):e1552. doi: 10.1371/journal.pntd.0001552. Epub 2012 Feb 28.

40.

Pneumococcal antibody concentrations and carriage of pneumococci more than 3 years after infant immunization with a pneumococcal conjugate vaccine.

Akinsola AK, Ota MO, Enwere GC, Okoko BJ, Zaman SM, Saaka M, Nsekpong ED, Odutola AA, Greenwood BM, Cutts FT, Adegbola RA.

PLoS One. 2012;7(2):e31050. doi: 10.1371/journal.pone.0031050. Epub 2012 Feb 20.

41.

Household concentrations and exposure of children to particulate matter from biomass fuels in The Gambia.

Dionisio KL, Howie SR, Dominici F, Fornace KM, Spengler JD, Adegbola RA, Ezzati M.

Environ Sci Technol. 2012 Mar 20;46(6):3519-27. doi: 10.1021/es203047e. Epub 2012 Feb 29.

42.

Pre-vaccination nasopharyngeal pneumococcal carriage in a Nigerian population: epidemiology and population biology.

Adetifa IM, Antonio M, Okoromah CA, Ebruke C, Inem V, Nsekpong D, Bojang A, Adegbola RA.

PLoS One. 2012;7(1):e30548. doi: 10.1371/journal.pone.0030548. Epub 2012 Jan 24.

43.

Monitoring the introduction of pneumococcal conjugate vaccines into West Africa: design and implementation of a population-based surveillance system.

Mackenzie GA, Plumb ID, Sambou S, Saha D, Uchendu U, Akinsola B, Ikumapayi UN, Baldeh I, Usuf E, Touray K, Jasseh M, Howie SR, Wattiaux A, Lee E, Knoll MD, Levine OS, Greenwood BM, Adegbola RA, Hill PC.

PLoS Med. 2012 Jan;9(1):e1001161. doi: 10.1371/journal.pmed.1001161. Epub 2012 Jan 17.

44.

The exposure of infants and children to carbon monoxide from biomass fuels in The Gambia: a measurement and modeling study.

Dionisio KL, Howie SR, Dominici F, Fornace KM, Spengler JD, Donkor S, Chimah O, Oluwalana C, Ideh RC, Ebruke B, Adegbola RA, Ezzati M.

J Expo Sci Environ Epidemiol. 2012 Mar-Apr;22(2):173-81. doi: 10.1038/jes.2011.47. Epub 2011 Dec 14.

PMID:
22166810
45.

Mixed infection with cagA positive and cagA negative strains of Helicobacter pylori lowers disease burden in The Gambia.

Secka O, Antonio M, Berg DE, Tapgun M, Bottomley C, Thomas V, Walton R, Corrah T, Thomas JE, Adegbola RA.

PLoS One. 2011;6(11):e27954. doi: 10.1371/journal.pone.0027954. Epub 2011 Nov 29.

46.

Antimicrobial resistance and virulence genes of non-typhoidal Salmonella isolates in The Gambia and Senegal.

Dione MM, Ikumapayi U, Saha D, Mohammed NI, Adegbola RA, Geerts S, Ieven M, Antonio M.

J Infect Dev Ctries. 2011 Nov 15;5(11):765-75.

47.

Rationale and expectations of the Pneumonia Etiology Research for Child Health (PERCH) study.

Adegbola RA, Levine OS.

Expert Rev Respir Med. 2011 Dec;5(6):731-3. doi: 10.1586/ers.11.74. No abstract available.

PMID:
22082158
48.

Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial.

Roca A, Hill PC, Townend J, Egere U, Antonio M, Bojang A, Akisanya A, Litchfield T, Nsekpong DE, Oluwalana C, Howie SR, Greenwood B, Adegbola RA.

PLoS Med. 2011 Oct;8(10):e1001107. doi: 10.1371/journal.pmed.1001107. Epub 2011 Oct 18.

49.

Identification of probable early-onset biomarkers for tuberculosis disease progression.

Sutherland JS, Hill PC, Adetifa IM, de Jong BC, Donkor S, Joosten SA, Opmeer L, Haks MC, Ottenhoff TH, Adegbola RA, Ota MO.

PLoS One. 2011;6(9):e25230. doi: 10.1371/journal.pone.0025230. Epub 2011 Sep 23.

50.

Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants.

Ota MO, Odutola AA, Owiafe PK, Donkor S, Owolabi OA, Brittain NJ, Williams N, Rowland-Jones S, Hill AV, Adegbola RA, McShane H.

Sci Transl Med. 2011 Jun 22;3(88):88ra56. doi: 10.1126/scitranslmed.3002461.

Supplemental Content

Loading ...
Support Center